These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 33791431)

  • 1. Development of Triantennary N-Acetylgalactosamine Conjugates as Degraders for Extracellular Proteins.
    Zhou Y; Teng P; Montgomery NT; Li X; Tang W
    ACS Cent Sci; 2021 Mar; 7(3):499-506. PubMed ID: 33791431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation.
    Ahn G; Banik SM; Miller CL; Riley NM; Cochran JR; Bertozzi CR
    Nat Chem Biol; 2021 Sep; 17(9):937-946. PubMed ID: 33767387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjugation with glucagon like peptide-1 enables targeted protein degradation.
    Zhu L; Zhou Y; Zhang B; Luo Y; Fang C; Yan X; Cai Y; Jiang L; Ge J
    Bioorg Chem; 2023 Dec; 141():106908. PubMed ID: 37827016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel approaches to targeted protein degradation technologies in drug discovery.
    Xue Y; Bolinger AA; Zhou J
    Expert Opin Drug Discov; 2023 Apr; 18(4):467-483. PubMed ID: 36895136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LYTACs: An Emerging Tool for the Degradation of Non-Cytosolic Proteins.
    Ramadas B; Kumar Pain P; Manna D
    ChemMedChem; 2021 Oct; 16(19):2951-2953. PubMed ID: 34296796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Integrin Targeting Chimeras (ITACs) for the Lysosomal Degradation of Extracellular Proteins.
    Zhou Y; Liao Y; Zhao Y; Tang W
    ChemMedChem; 2024 Dec; 19(24):e202300643. PubMed ID: 39245642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aptamer-LYTACs for Targeted Degradation of Extracellular and Membrane Proteins.
    Wu Y; Lin B; Lu Y; Li L; Deng K; Zhang S; Zhang H; Yang C; Zhu Z
    Angew Chem Int Ed Engl; 2023 Apr; 62(15):e202218106. PubMed ID: 36722696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidating the cellular determinants of targeted membrane protein degradation by lysosome-targeting chimeras.
    Ahn G; Riley NM; Kamber RA; Wisnovsky S; Moncayo von Hase S; Bassik MC; Banik SM; Bertozzi CR
    Science; 2023 Oct; 382(6668):eadf6249. PubMed ID: 37856615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysosome-targeting chimaeras for degradation of extracellular proteins.
    Banik SM; Pedram K; Wisnovsky S; Ahn G; Riley NM; Bertozzi CR
    Nature; 2020 Aug; 584(7820):291-297. PubMed ID: 32728216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the undruggables-the power of protein degraders.
    Zhang C; Liu Y; Li G; Yang Z; Han C; Sun X; Sheng C; Ding K; Rao Y
    Sci Bull (Beijing); 2024 Jun; 69(11):1776-1797. PubMed ID: 38614856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Lysosome Targeting Chimera for Targeted Protein Degradation via Split-and-Mix Strategy.
    Wang J; Wang Y; Yang F; Luo Q; Hou Z; Xing Y; Lu F; Li Z; Yin F
    ACS Chem Biol; 2024 May; 19(5):1161-1168. PubMed ID: 38662199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte-specific delivery of siRNAs conjugated to novel non-nucleosidic trivalent N-acetylgalactosamine elicits robust gene silencing in vivo.
    Rajeev KG; Nair JK; Jayaraman M; Charisse K; Taneja N; O'Shea J; Willoughby JL; Yucius K; Nguyen T; Shulga-Morskaya S; Milstein S; Liebow A; Querbes W; Borodovsky A; Fitzgerald K; Maier MA; Manoharan M
    Chembiochem; 2015 Apr; 16(6):903-8. PubMed ID: 25786782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted degradation of membrane and extracellular proteins with LYTACs.
    Li YY; Yang Y; Zhang RS; Ge RX; Xie SB
    Acta Pharmacol Sin; 2024 Aug; ():. PubMed ID: 39103530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted degradation of extracellular secreted and membrane proteins.
    Chen X; Zhou Y; Zhao Y; Tang W
    Trends Pharmacol Sci; 2023 Nov; 44(11):762-775. PubMed ID: 37758536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PROTAC targeted protein degraders: the past is prologue.
    Békés M; Langley DR; Crews CM
    Nat Rev Drug Discov; 2022 Mar; 21(3):181-200. PubMed ID: 35042991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of GalNAc-siRNA Conjugate Activity in Pre-clinical Animal Models with Reduced Asialoglycoprotein Receptor Expression.
    Willoughby JLS; Chan A; Sehgal A; Butler JS; Nair JK; Racie T; Shulga-Morskaya S; Nguyen T; Qian K; Yucius K; Charisse K; van Berkel TJC; Manoharan M; Rajeev KG; Maier MA; Jadhav V; Zimmermann TS
    Mol Ther; 2018 Jan; 26(1):105-114. PubMed ID: 28988716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nano-LYTACs for Degradation of Membrane Proteins and Inhibition of CD24/Siglec-10 Signaling Pathway.
    Wang K; Yu A; Liu K; Feng C; Hou Y; Chen J; Ma S; Huang L; Dai X
    Adv Sci (Weinh); 2023 May; 10(13):e2300288. PubMed ID: 36866919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bifunctional small molecules that mediate the degradation of extracellular proteins.
    Caianiello DF; Zhang M; Ray JD; Howell RA; Swartzel JC; Branham EMJ; Chirkin E; Sabbasani VR; Gong AZ; McDonald DM; Muthusamy V; Spiegel DA
    Nat Chem Biol; 2021 Sep; 17(9):947-953. PubMed ID: 34413525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Oligomeric Mannose-6-phosphonate Conjugates for Targeted Protein Degradation.
    Stevens CM; Zhou Y; Teng P; Rault LN; Liao Y; Tang W
    ACS Med Chem Lett; 2023 Jun; 14(6):719-726. PubMed ID: 37312839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective degradation of EGFR
    Qu X; Liu H; Song X; Sun N; Zhong H; Qiu X; Yang X; Jiang B
    Eur J Med Chem; 2021 Jun; 218():113328. PubMed ID: 33773286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.